This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Close Message
NextPharmaJob.com for pharmaceutical industry jobs
Lucid Group
NextPharmaJob.com is dedicated to putting job seekers looking for pharmaceutical industry jobs in touch with recruiters and employers.
Browse Jobs Search Jobs

To receive a FREE weekly email alert of all the latest pharmaceutical industry jobs added to our database enter your email address below.

Submit | Tell me more...

Sister sites:
Our sister site Our sister site
Partner sites:

At Burntsky Limited we work with a number of third parties in order to maximise the reach of the jobs posted with us including but not limited to:

JooblePartner Jooble
UK Jobs
Science Jobs

Industry News
18 January 2017 13:05Aytu BioScience Announces Two Presentations Highlighting Benefits of Natesto® (Testosterone) Nasal Gel in Men at American Urological Association Annual Meeting
ENGLEWOOD, Colo., Jan. 18, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that two posters demonstrating cl

18 January 2017 13:00Tarix Orphan Receives Rare Pediatric Disease Designation for TXA127 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
CAMBRIDGE, Mass., Jan. 18, 2017 /PRNewswire/ -- Tarix Orphan LLC today announced that the U.S. Food and Drug Administration has granted a Rare Pediatric Disease (RPD) designation for the company's drug candidate TXA127 for the treatment of Recessiv

18 January 2017 13:00Abbott Announces European Launch of the Proclaim(TM) DRG Neurostimulation System for the Management of Chronic Neuropathic Pain
ABBOTT PARK, Ill., Jan. 18, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the European launch of the new Proclaim™ DRG Neurostimulation System, designed to deliver dorsal root ganglion (DRG) stimulation to patients suffering from chronic

18 January 2017 13:00FDA Grants Fast Track Designation for aTyr's Resolaris(TM) to Treat Limb Girdle Muscular Dystrophy 2B and Removes Partial Clinical Hold for Resolaris
SAN DIEGO, Jan. 18, 2017 /PRNewswire/ -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced that its product candi

18 January 2017 13:00Ximbio Opens North America Office in Cambridge, Massachusetts
LONDON, January 18, 2017 /PRNewswire/ -- Ximbio, a non-profit online one-stop-shop for the global life science community to share research resources, has opened its first North American headquarters in Kendall Square, Cambridge, Massachusetts. Th

18 January 2017 13:00Eisai to Participate in Access Accelerated, Global Partnership to Address Rise of Non-Communicable Diseases
WOODCLIFF LAKE, N.J., Jan. 18, 2017 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that it is participating in Access Accelerated, a global partnership to advance access to non-communicable diseas

18 January 2017 13:00Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with HER3-Positive Metastatic or Unresectable Breast Cancer
TOKYO and PARSIPPANY, N.J., Jan. 18, 2017 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today the initiation of a three-part open-label phase 1/2 study in Japan with U3-1402, a novel HER3-targeting antibody d

18 January 2017 13:00Abbott Announces European Launch of the Proclaim™ DRG Neurostimulation System for the Management of Chronic Neuropathic Pain
SYSTEM COMBINES SUPERIOR PAIN RELIEF WITH AN INTUITIVE APPLE™ TECHNOLOGY PROGRAMMING PLATFORM - DRG stimulation has been clinically proven to provide pain relief directly to the area of the body where pain occurs to improve quality of life - Now

18 January 2017 13:00Bayer to Present Latest Stivarga Data at ASCO GI 2017
WHIPPANY, N.J., Jan. 18, 2017 /PRNewswire/ -- Bayer announced today that the company will present seven abstracts on Stivarga® (regorafenib) in advanced liver and colorectal cancers at the 2017 American Society of Clinical Oncology Gastrointestinal

18 January 2017 12:30Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO
CAMBRIDGE, Mass., Jan. 18, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) ("Merrimack" or the "Company") today announced that Richard Peters, M.D., Ph.D., has been appointed as the Company's President and Chief Executive Office

18 January 2017 12:10Technical Reports on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson
NEW YORK, January 18, 2017 /PRNewswire/ -- Today, Stock-Callers.com takes another look at the Drug Manufacturers space to see how current market conditions are influencing the performances of some major players in the industry. Under evaluation th

18 January 2017 11:53Dopo avere ottenuto la certificazione CE, Medasense lancia un nuovo dispositivo di monitoraggio del dolore, il PM D200[TM]
RAMAT GAN, Israele, January 18, 2017 /PRNewswire/ --  - La nuova tecnologia all'avanguardia aiuta gli esperti a offrire trattamenti del dolore personalizzati Medasense Biometrics Ltd. ha annunciato oggi di avere ricevuto l'approvazione CE per

18 January 2017 11:45Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
INDIANAPOLIS and CAMBRIDGE, Mass., Jan. 18, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and CoLucid Pharmaceuticals, Inc. (NASD: CLCD) today announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 m

18 January 2017 11:43Medasense lance un nouveau dispositif de surveillance de la douleur, le PMD200[TM], après obtention de la certification européenne CE
RAMAT GAN, Israël, January 18, 2017 /PRNewswire/ -- - Une nouvelle technologie de pointe aide les cliniciens à soulager la douleur de leurs patients en fonction de leurs besoins Medasense Biometrics Ltd. a annoncé aujourd'hui avoir obtenu la

18 January 2017 10:22Medasense launch PMD200[TM] nach CE-Kennzeichung in Europa, neues Produkt zur Schmerzmessung
RAMAT GAN, Israel, January 18, 2017 /PRNewswire/ --  - Neue hochmoderne Technologie ermöglicht personalisierte Schmerzlinderung durch den Arzt Wie Medasense Biometrics Ltd. heute bekanntgab, hat es für sein neuartiges Produkt zur Schmerzmessung P

18 January 2017 10:00Artemisinin Market 2021 Top Manufacturers Analysis and Forecast Research Report
PUNE, India, January 18, 2017 /PRNewswire/ -- Global Artemisinin Market 2017 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into

18 January 2017 09:30Thorn Medical PLC Appoints Paul Morton as Chief Executive Officer and Jack Kaye as Executive Chairman
LONDON, January 18, 2017 /PRNewswire/ -- Thorn Medical PLC ("Thorn" or the "Company"), the international healthcare group, today announces the appointment of Paul Morton as Chief Executive Officer and Jack Kaye as Executive Chairman, who replaces

18 January 2017 09:10Medasense Launches New Pain Monitoring Device, PMD200[TM] Following European CE Approval
RAMAT GAN, Israel, January 18, 2017 /PRNewswire/ --  - New state-of-the-art technology helps clinicians provide personalised pain relief Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring

18 January 2017 08:00Ximbio Opens North America Office in Cambridge, Massachusetts
LONDON, January 18, 2017 /PRNewswire/ -- Ximbio, a non-profit online one-stop-shop for the global life science community to share research resources, has opened its first North American headquarters in Kendall Square, Cambridge, Massachusetts. Th

18 January 2017 05:01SilverCloud Health Raises $8.1 Million to Accelerate Delivery of Evidence-based Digital Mental Health and Behavioural Healthcare Solutions
BOSTON and DUBLIN, January 18, 2017 /PRNewswire/ -- Digital Health company SilverCloud Health, the leading provider of evidence-based online mental health and behavioural healthcare solutions, announced that it has raised $8.1 million in Series A
News last updated 18/01/2017 13:07:04
line graphic

Compatible with:

JobMate   Broadbean   Idibu

Site optimised for Internet Explorer 8+ / Firefox 3+
View a complete Jobs Listing



Credit cards image